Cargando…

Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma

Detalles Bibliográficos
Autores principales:	Hsu, Chi-Kuei, Lai, Chih-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2022
Materias:	Correspondence and Replies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538625/ https://www.ncbi.nlm.nih.gov/pubmed/36216467 http://dx.doi.org/10.1016/j.jaip.2022.06.051

Ejemplares similares

Reply to “Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma”
por: Feng, Lan, et al.
Publicado: (2022)

The impact of inhaled corticosteroid on SARS-CoV2 infection
por: Lai, Chih-Cheng
Publicado: (2021)

Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Does asthma affect outcomes of patients with COVID-19 infections?
por: Kalemci, Serdar, et al.
Publicado: (2021)

Reply to “Does asthma affect outcomes of patients with COVID-19 infections?”
por: Mahdavinia, Mahboobeh, et al.
Publicado: (2021)

A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter
por: Maeda, Yohei, et al.
Publicado: (2022)

Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter"
por: Strauss, Ronald, et al.
Publicado: (2022)

The association between immunosuppressant and the outcome of COVID-19
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma
por: Beasley, Richard, et al.
Publicado: (2019)

The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2021)

Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Reply to Lipworth et al.: Inhaled Corticosteroids and COVID-19
por: Maes, Tania, et al.
Publicado: (2020)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
por: Adir, Yochai, et al.
Publicado: (2022)

Inhaled corticosteroids: not just for asthma, but for COVID-19?
por: Liew, Felicity, et al.
Publicado: (2022)

Mortality-related immune features and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Reply to “PEG skin testing for COVID-19 allergy”
por: Banerji, Aleena, et al.
Publicado: (2021)

PEG skin testing for COVID-19 vaccine allergy
por: Stone, Bryan D.
Publicado: (2021)

Reply to “Mortality-related immune features and COVID-19”
por: Cai, Li, et al.
Publicado: (2021)

COVID-19 “infodemics” and asthmatic children: The return to school challenge
por: Boechat, José Laerte, et al.
Publicado: (2021)

How important is the second dose of the COVID-19 mRNA vaccine?
por: Liu, Anne Y.
Publicado: (2021)

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
por: Shaker, Marcus S., et al.
Publicado: (2021)

Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium
por: Tricarico, Gerardo, et al.
Publicado: (2021)

Reply to “The forced renaissance of telemedicine during COVID-19: A fellow-in-training's perspective”
por: Bansal, Priya, et al.
Publicado: (2021)

Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era
por: Mesli, Farah, et al.
Publicado: (2021)

Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?
por: Drake, Matthew G., et al.
Publicado: (2021)

Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium”
por: Ballow, Mark, et al.
Publicado: (2021)

Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era”
por: Lang, Claudia Cécile Valérie, et al.
Publicado: (2021)

Reply to “Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?”
por: Ferastraoaru, Denisa, et al.
Publicado: (2021)

Effect of inhaled corticosteroids on systemic inflammation in asthma
por: Karthikeyan, Ramaraju, et al.
Publicado: (2014)

Risk of severe COVID-19 infection in International Space Station astronauts despite routine pre-mission measures
por: Javad Mortazavi, Seyed Mohammad, et al.
Publicado: (2021)

Reply to “Risk of severe COVID-19 infection in International Space Station astronauts despite routine pre-mission measures”
por: Crucian, Brian E., et al.
Publicado: (2021)

Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021)

SARS-CoV-2 reinfection or persistence among immunodeficient patients
por: Özdemir, Öner
Publicado: (2023)

Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients”
por: Marcus-Mandelblit, Nufar, et al.
Publicado: (2023)

COVID-19 and upper respiratory tract: Collecting swab specimens from patients inhaling corticosteroids
por: Siniorakis, Eftychios, et al.
Publicado: (2020)

Impact of more variations on in‐hospital mortality among patients with confirmed COVID‐19
por: Jia, Na, et al.
Publicado: (2022)

Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines
por: Mathes, Sonja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1su8s81gmkdjg93frh15dvo46v